GenderSci Lab
LightNews LightNews
genderscilab.bsky.social
GenderSci Lab
@genderscilab.bsky.social
2.1K followers 460 following 79 posts
Feminist research lab at Harvard University dedicated to generating concepts, methods, and theories for scientific research on sex and gender.
Posts Replies Media Videos
genderscilab.bsky.social
We are excited to share the upcoming release of Seminal, a groundbreaking collection exploring sperm as a lens into the complex intersections of biology, politics, and health. Lab member Marion Boulicault contributed a chapter based on our sperm decline work.
Flyer for new book, "Seminal: On Sperm, Health, and Politics", available June 2025 for $32.00, edited by Rene Almeling, Lisa Campo-Engelstein and Brian T. Nguyen.
May 12, 2025 at 7:17 PM
genderscilab.bsky.social
Join author Agustín Fuentes (@anthrofuentes.bsky.social) in conversation with GenderSci Lab Director Sarah Richardson (@profrichardson.bsky.social) about his new book, Sex is a Spectrum: The Biological Limits of the Binary.

📍Harvard Book Store
📆 Tuesday May 13, 7 PM

www.harvard.com/event/agust%...
May 6, 2025 at 2:28 PM
genderscilab.bsky.social
White text on teal background: "Investment feminism: 1. Highlights how financialization may intensify a feminist politics that prioritizes individualization and self-optimization (a concept known as neoliberal feminism) 2. Identifies the articulation of financial investment as a power lever for social changes 3. Predicts increased technologization and datafication at the intersection between capitalism and feminism." Citation: Marsella et al., "Investment Feminism and Women's Health." Signs. GenderSci Lab logo in the bottom right corner.
April 2, 2025 at 4:23 PM
genderscilab.bsky.social
Join The Intersectionality Training Institute on Thursday, March 12 from 5:00 to 6:30PM EDT for a salon hosted by Dr. Elle Lett featuring GenderSci Lab Director Sarah Richardson on Sex, Gender, Law, Policy & How We Got Here.

Register here: us06web.zoom.us/webinar/regi...
March 11, 2025 at 1:43 PM
genderscilab.bsky.social
📣 Symposium 3: Sex, Gender, and Sexuality in the Journal
Wednesday Nov 20, 12–2 PM EST

Presented by Harvard Medical School, the Center for the History of Medicine, and New England Journal of Medicine.

Featuring GSL Speakers: Ben Maldonado, Jamie Marsella, Abigail Higgins, & Sarah Richardson.
November 13, 2024 at 10:11 PM
genderscilab.bsky.social
We show that the Journal helped promote sexist ideas about fundamental differences between women and men. These ideas have had long-term implications for the treatment of patients – and for whose voices are included in medicine:
Over the past two centuries, articles in NEJM have: Argued that women were incapable of being doctors due their supposed delicate nature, menstrual cycle, and reproductive weakness. Attributed a variety of conditions to the reproductive organs of women, especially mental illness Used women’s fertility as a sign of their overall health Portrayed intersex people as medical oddities and, at times, used them as subjects of medical study without consent.
June 6, 2024 at 4:56 PM
genderscilab.bsky.social
Are you passionate about feminist science? Come work with us at the GenderSci Lab!! We are recruiting for a 2-3 year lab manager position starting between April through June 2024. Full description and application information here: www.genderscilab.org/blog/the-gen...
February 21, 2024 at 3:15 PM
genderscilab.bsky.social
Reports of ADEs occur after a number of steps, and the Gender Hypothesis proposes pathways by which gender can influence the next step in the process
Flow diagram of the process by which ADEs are reported and the gendered pathways that act on each step. The 4 gendered pathways are: #1 healthcare utilization, #2 bias & discrimination in the clinic, #3 experience of a drug event as adverse, #4 preexisting social/structural health vulnerabilities. Step 1 in the process is “having a condition for which drug treatment is possible.” Pathway #4 acts here. Exiting the process is “not receiving a diagnosis or drug treatment.” Step 2 is “diagnosis & receiving a drug treatment.” Pathways #1, 2, & 3 act here. Exiting the process is “not identifying an experience as an ADE.” Step 3 is “identifying an experience as an ADE.” Pathways #1, 2, & 3 act here. Exiting the process is “not reporting ADE to a database.” Step 4 is “reporting an ADE to a database.” Pathways #1, 2, & 3 act here.
November 29, 2023 at 9:28 PM